Stockreport

Diving Into Deciphera Pharmaceuticals [Seeking Alpha]

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations
PDF Vimseltinib is expected to make significant progress in the TGCT indication, as the only approved therapy is under a Risk Evaluation and Mitigation Strategy protocol. [Read more]